Form 4: Carlyle Group Sells QuidelOrtho Corp Shares Under 10b5-1 Trading Plan

The Carlyle Group executed multiple sales of QuidelOrtho Corp shares between July 10 and July 11, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• The Carlyle Group, a significant shareholder of QuidelOrtho Corp, has sold shares of common stock.
• The sales occurred on July 10 and July 11, 2024.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• On July 10, 2024, 24,390 shares were sold at a weighted average price of $30.0931, with individual prices ranging from $30.00 to $30.23.
• On July 11, 2024, multiple sales occurred: 4,724 shares at a weighted average price of $30.6844 (ranging from $30.10 to $30.9998), 91,594 shares at $31.408 (ranging from $31.00 to $31.9998), and 260 shares at $32.0096 (ranging from $32.00 to $32.0336).
• Following these transactions, the Carlyle Group's indirect beneficial ownership stands at 11,045,002 shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting share sales. It is neutral in tone and doesn't inherently indicate positive or negative sentiment. The sales are pre-planned.

Risks

• The Carlyle Group's continued sales of QuidelOrtho shares could exert downward pressure on the stock price.

Industry Context

Sales by major shareholders are common and can be driven by various factors, including portfolio rebalancing or profit-taking. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on current market conditions.

Stakeholder Impact

• Shareholders may react to the news of the Carlyle Group selling shares, potentially impacting the stock price.

Key Dates